The dvm360® pharmacy page is a comprehensive resource for clinical news and insights on the latest veterinary pharmacy. This page consists of articles, videos, interviews that include research on advancements and developments of therapies for veterinary care, and FDA approvals.
Advances in technology reduce inefficiencies, saving time and money
Veterinary tranquilizer does not respond to opioid-reversing drugs like naloxone, contributing to an increase in overdose deaths
A boarded oncologist provides insight into how affordable, older medications can open the door to alternative options for managing these diseases
The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.
Melissa King, PharmD, explains the difference between beyond-use dates and expiration dates and how upcoming USP changes may impact inventory
Ingesting of human psychiatric drugs can cause clinical signs ranging from sympathomimetic to anticholinergic